Dose response of continuous subcutaneous infusion of recombinant glucagon-like peptide-1 in combination with metformin and sulphonylurea over 12 weeks in patients with type 2 diabetes mellitus

Signe Sørensen Torekov, J J Holst, M R Ehlers

11 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Dose response of continuous subcutaneous infusion of recombinant glucagon-like peptide-1 in combination with metformin and sulphonylurea over 12 weeks in patients with type 2 diabetes mellitus'. Sammen danner de et unikt fingeraftryk.

Medicin og biovidenskab